CW
CRBP icon

Curio Wealth’s Corbus Pharmaceuticals CRBP Stock Holding History

Curio Wealth’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23
Closed -$216 – 307
2026
Q1 		$216 Hold
23
– – ﹤0.01% 745
2025
Q4 		$194 Hold
23
– – ﹤0.01% 431
2025
Q3 		$291 Hold
23
– – ﹤0.01% 264
2025
Q2 		$159 Buy
23
+22
+2,200% +$160 ﹤0.01% 337
2025
Q1 		$271 Sell
1
-22
-96% -$194 ﹤0.01% 362
2024
Q4 		$271 Buy
+23
New +$386 ﹤0.01% 289

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Curio Wealth's CRBP Position: Q2 2026 in Review

Curio Wealth sold out of Corbus Pharmaceuticals (CRBP) in Q2 2026, closing a stake of 23 shares — an estimated $216 sold.

Curio Wealth first reported a position in CRBP in Q4 2024 and held it in 6 quarters. The position peaked at $291 in Q3 2025. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Curio Wealth reported no remaining Corbus Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Curio Wealth sold 23 Corbus Pharmaceuticals shares in Q2 2026, an estimated $216.
  • Curio Wealth first reported a position in Corbus Pharmaceuticals in Q4 2024 and held it in 6 quarters.
  • Curio Wealth's Corbus Pharmaceuticals position peaked at $291 in Q3 2025.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Curio Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.